Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Gero Miesenböck will give the 2018 Francis Crick Lecture on Wednesday 24th October 2018 at the MRC Laboratory of Molecular Biology, Cambridge. The lecture, entitled “Light Sleep” is open to anyone in the local area who is interested in attending.

Gero Miesenböck will give the 2018 Francis Crick Lecture entitled “Light Sleep”

The Lecture, will illustrate the enabling power of optogenetics with recent work on the homeostatic regulation of sleep. Optogenetic interventions have helped to pinpoint neurons whose sleep-inducing activity switches on as sleep deficits accrue, reveal how this activity switch works, and furnish a molecular interpretation of sleep pressure, its accumulation, and its discharge.

The Francis Crick Lecture is named in honour of LMB Nobel Laureate Francis Crick.  It is one of a series of named lectures organised by the LMB to be given by eminent scientists from around the world.

Gero is Waynflete Professor of Physiology and founding Director of the Centre for Neural Circuits and Behaviour at the University of Oxford. In 2002, Gero established the principles of optogenetic control and thereby defined a new, now widely used, approach for probing the function of the nervous system. He was the first scientist to modify neurons genetically so that their electrical activity could be controlled with light. This involved inserting DNA for light-responsive opsin proteins into the cells. Gero used similar genetic modifications to breed animals whose brains contained light-responsive neurons integrated into their circuitry, and was the first to demonstrate that the behaviour of these animals could be remote-controlled. He continues to use optogenetics in his current research, which centres on the biophysics of temporal information processing in decision-making and the regulation of sleep.

Gero studied medicine at the University of Innsbruck in his native Austria and did postdoctoral research at Memorial Sloan-Kettering Cancer Center in New York. He was on the faculty of Yale University before joining the University of Oxford in 2007.

Gero’s awards for his invention of optogenetics include the InBev-Baillet Latour International Health Prize (2012), The Brain Prize (2013), and the Massry Prize (2016). He was elected a fellow of the Royal Society in 2015, and is a member of the German and Austrian Academies of Science.

 

The 2018 Francis Crick Lecture will be held on Wednesday on Wednesday 24th October 2018 at 11.00am in the Max Perutz Lecture Theatre at the Laboratory of  Molecular Biology Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK

Similar stories

Randy Bruno named Academy of Medical Sciences Professor

Congratulations are in order for Professor Randy Bruno, who has been awarded an AMS Professorship. The AMS Professorship Scheme provides a package of support to biomedical and healthcare researchers taking up a full Professorship in the UK.

Nicola Smart appointed Associate Professor of Cellular and Integrative Physiology

The post is in association with a Tutorial Fellowship at Christ Church College.

Professor Irene Tracey CBE FMedSci nominated as next Oxford Vice-Chancellor

Congratulations are in order for Professor Irene Tracey, Warden of Merton College and former University Lecturer at DPAG, who has been nominated as the next Vice-Chancellor of the University of Oxford.

DPAG researchers showcased at premier European Society of Cardiology meeting

DPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.

Oxford Parkinson’s Disease Centre awarded £3.8 million to reveal the role of calcium in Parkinson’s

A collaborative research team led by the Oxford Parkinson’s Disease Centre (OPDC) has been awarded a £3.8 million Wellcome Trust Collaborative Award to study the function of calcium in dopamine neurons, and how this is plays a role in Parkinson’s. Their research will help explain how and why dopamine neurons are vulnerable in the disease and look at how they may be preserved.